Objective To assess the association of first pregnancy preterm prelabour rupture of membranes (PPROM) with adverse maternal and perinatal outcomes in the next pregnancy.
Introduction
There are few public health issues as important as preterm birth. Rates continue to rise in developed countries, and it remains the most important single determinant of adverse infant outcome. 1 Despite preterm prelabour rupture of membranes (PPROM) complicating only 2-5% of pregnancies, it is implicated in up to 40% of preterm births and therefore a leading cause of not only preterm birth but the maternal, fetal and neonatal morbidity and mortality that follow. [2] [3] [4] [5] The cause of PPROM is multi-factorial with demographic, lifestyle, medical conditions, invasive tests and treatments, structural abnormalities, bleeding, genital colonisation, infections and prior history of PPROM or preterm birth implicated. 2, 5, 6 Despite these associations, PPROM often occurs without an identifiable cause.
With PPROM, most cases are hospitalised. Chorioamnionitis and postpartum infection are common sequelae, and maternal death due to sepsis can occur. Placental abruption is more common in PPROM pregnancies and more so if infection is present. 7 For the baby, most complications relate to prematurity, including respiratory distress syndrome, sepsis, risks of oligohydramnios, intraventricular haemorrhage, necrotising enterocolitis, cerebral palsy and perinatal death. 1, 4, 8 For those that survive, educational and behavioural issues persist into school-age 9 and adulthood. 10 Expensive in human and healthcare costs, data suggest that PPROM birth costs are eight times that of uncomplicated births, 11 while indirect costs include family challenges from the onset of PPROM to delivery, postnatally and through the life course of the child. 12 Regarding the next pregnancy, few researchers have studied pregnancy following PPROM, [13] [14] [15] [16] confirming the tendency of PPROM to recur 13, 14 and to result in preterm delivery. 15, 16 None has looked at maternal and perinatal implications for the next pregnancy, information vital for affected parents and their carers. We report on pregnancy outcomes in the second singleton pregnancy in women with a history of PPROM in their first birth from a cohort of 37 776 women having a first singleton birth.
Methods

Data source
The Aberdeen Maternity and Neonatal Databank (AMND) has collected data for all pregnancies in Aberdeen city and district in the North East of Scotland since the 1950s. Pregnancy follow up is facilitated by a stable population within a defined geographical region where unique identifiers link records for individual women's pregnancies (detailed at www.abdn.ac. uk/amnd). The AMND was used to provide anonymised data for analysis. Complications related to pregnancy and delivery, as well as related co-morbidities, are coded using criteria taken from the ninth and tenth revisions of the International Classification of Diseases (ICD-9 and -10).
Study population
The study population comprised of all primiparous women who delivered their first singleton baby between 1986 and 2005. Women were followed up until December 2012 to identify any second pregnancy, to give the women in the cohort a fair chance of having another pregnancy. The year 2012 was taken as the end date, as that was the year when data entry was complete at the time of data extraction and analysis. To reduce heterogeneity of the study population, multiple gestations were excluded due to their known association with PPROM.
Study design and definitions
A retrospective cohort study design was used, where the exposed and unexposed cohorts comprised of women who had or did not have PPROM in the first pregnancy, respectively. Potential confounders were extracted, including age at first delivery, body mass index (BMI), smoking status, social class and marital status. Age was given in completed years at the time of delivery and was further subgrouped into: <20, 20-34, 35-39 and ≥40 years. Smoking was coded in the databank as self-reported number of cigarettes at booking, and was recoded as non/ex-smoker and current smoker for analysis. BMI was calculated by dividing antenatal booking weight (kg) by height squared (m). The BMI was then recoded into the following five categories: <20 kg/m 2 , 20 to <25 kg/m 2 , 25 to <30 kg/m 2 , 30 to <35 kg/m 2 and ≥35 kg/m 2 . Social class was defined by the husband/partners' occupation at booking, as categorised by the Registrar General's Classification (1951). Where no male occupation was stated, the women's own occupation was used. The six social classes were re-categorised to non-manual (I, II and IIINM) or manual (IIIM, IV and V), with non-manual acting as the reference category. Marital status comprised the variables: married/cohabitating and non-married/cohabiting.
The most common definition of PPROM is the rupture of fetal membranes before 37 weeks gestation and the onset of labour. 17 A stricter definition of rupture at least 1 hour prior to contraction onset has been used more recently and was adopted for this study. 18 PPROM, as a variable, was defined as rupture of membranes between 24 +0 and 36 +6 weeks of gestation, at least 1 hour prior to the onset of labour. Gestation age was derived primarily from date of last normal menstrual period, but adjusted if dates by ultrasound scanning differed by greater than 7 days. In terms of outcomes assessed at first pregnancy, the proportion of women with threatened miscarriage, pregnancyinduced hypertension (PIH), pre-eclampsia (PE), antepartum haemorrhage (APH), type of labour (spontaneous and induced), mode of delivery [spontaneous vaginal (cephalic and breech), instrumental and caesarean], preterm and low birth weight (LBW) in the first pregnancy were compared between the exposed and unexposed cohorts.
In the second pregnancy, the following outcomes were assessed: the proportion of women who went on to have a second pregnancy, MC (pregnancy loss <24 weeks), ectopic pregnancy (pregnancy outside the uterine cavity; including pregnancy of unknown location), termination of pregnancy (TOP), PIH (diastolic blood pressure >90 mmHg on two occasions 4 hours apart, or a single reading of >110 mmHg from 20 weeks gestation), PE (PIH + proteinuria 0.3 g/ 24 hours), APH (placental abruption, praevia) and postpartum haemorrhage (PPH; blood loss >500 ml for vaginal delivery, >1000 ml for caesarean), type of labour (spontaneous and induced), mode of delivery [spontaneous vaginal (cephalic and breech), instrumental and caesarean] and PPROM in the second pregnancy. Neonatal outcomes included stillbirth (delivery of a dead baby at or after 24 +0 weeks gestation), preterm birth (24 +0 to 36 +6 weeks of gestation), LBW (<2500 g), neonatal death (death of a liveborn infant in the first 4 weeks of life), neonatal infections (according to ICD-10 codes P35-39) and admission to neonatal intensive care.
Statistical analyses
Statistical analyses were performed using SPSS version 20 (IBM, SPSS Statistics, Armonk, NY, USA). Descriptive statistics were reported as means and standard deviations for continuous variables and percentages for categorical variables. Differences in demographics and first pregnancy outcomes between the exposed and unexposed cohorts were assessed using Chi-square test. Pregnancy and neonatal outcomes in the second pregnancy were analysed using univariate (corresponding to Model 1 in Table 2 , unadjusted for covariates) and multivariable statistical methods (corresponding to Model 2 in Table 2 , adjusted for potential confounders to ascertain whether relationships were due to demographic characteristics or adverse obstetric events; these included maternal age, social class, smoking status, marital status and threatened MC, PIH, PE, APH and mode of delivery in first pregnancy). To look for interaction of obstetric practice over time, the year of delivery was entered as an independent variable into the logistic regression model. Statistical significance was set at P < 0.05. Any variable found to be statistically significant on univariate analysis was entered into the multivariable model. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using binary logistic regression (backward likelihood ratio method). Model fit was assessed using Hosmer and Lemeshow goodness-of-fit criteria.
Results
Population demographics
Between 1986 and 2005, a total of 56 015 births was recorded, out of which 40 452 women had their first singleton delivery between 1 January 1986 and 31 December 2005. A total of 2676 women (6.6%) had missing rupture of membrane data, leaving 37 776 women with complete data for analysis. A total of 1979 women (5.2%) had a history of PPROM in their first pregnancy ( Figure 1 ).
Demographic characteristics between the exposed and unexposed cohorts are compared in Table 1 . Women with PPROM were more likely to be younger than 20 years old (8.3 versus 6.4%; P = 0.018), belong to manual social class (57.3 versus 53.6%; P = 0.002), smoke (23.5 versus 21.2%; P = 0.011), and not married/cohabitating (13.9 versus 11.3%; P < 0.001). No differences in smoking, socio-economic and marital status were observed between women with missing and no missing rupture of membrane data.
First pregnancy characteristics
Characteristics of first pregnancy between the exposed and unexposed cohorts are presented in Table 1 APH, antepartum haemorrhage; BMI, body mass index; LBW, low birth weight; MC, miscarriage; PE, pre-eclampsia; PIH, pregnancy-induced hypertension; PPROM, preterm prelabour rupture of membranes. *P-value determined with the use of a chi-square analysis.
P < 0.0001), APH (22.9 versus 9.6%; P < 0.0001), preterm delivery (98.2 versus 1.8%; P < 0.0001) and LBW (54.9 versus 3.8%; P < 0.0001). In contrast, PPROM women were less likely to have PIH (10.6 versus 17.5%; P < 0.0001) and instrumental delivery (12.5 versus 16.1%; P < 0.0001).
Second pregnancy
Of the 37 776 women, 22 034 (58.3%) went on to have a second pregnancy within the follow-up period. In the exposed cohort (n = 1979), 1174 women (59.3%) went on to have a second pregnancy; while within the unexposed cohort (n = 35 797), 20 860 women (58.3%) went on to have a subsequent pregnancy. Between the exposed and unexposed cohorts, no significant difference was observed for the likelihood of having a second singleton pregnancy ( Table 2) . +6 weeks) PPROM with no PPROM showed comparative associations with PPROM in the next pregnancy. Women with early PPROM in the first pregnancy showed stronger associations with the maternal complications of PIH, PE, instrumental and caesarean delivery in the second pregnancy, while APH and reduced TOP in the second pregnancy was stronger in women with late PPROM (Table S2) . 1.1-1.9 ). Given the high risk of PPROM in the subsequent pregnancy, we performed a subgroup analysis of neonatal outcomes in women who did not have a recurrent PPROM. In this subgroup, women with previous PPROM were 1.6 times more likely to have their baby admitted to neonatal unit (95% CI: 1.3-2.0) compared with women without previous PPROM (Table S1 ). A subgroup analysis by gestation at PPROM comparing early (24 +0 -33 +6 weeks) and late (34 +0 -36 +6 weeks) PPROM with no PPROM indicated that women with early PPROM in the first pregnancy showed stronger associations with the neonatal complications of preterm delivery, admission to the neonatal unit, neonatal infections, neonatal death and LBW in the second pregnancy (Table S2) .
Second pregnancy maternal outcomes
Second pregnancy neonatal outcomes
Discussion
Main findings
Our results indicate that a history of PPROM in the first singleton pregnancy was associated with an equal likelihood in achievement of second pregnancy, but an increased risk of adverse maternal and neonatal outcomes in that singleton pregnancy. These included a higher risk of recurrent PPROM, instrumental and caesarean delivery, PE, PIH and APH in the mother; and neonatal infection, death, admission to neonatal unit, preterm delivery and LBW in the baby. Even in women without a recurrence of PPROM, there was still a significant increase in risk of PIH, PE, instrumental and caesarean delivery, and neonatal unit admission.
Strengths and limitations
To our knowledge, this is the only epidemiological study exploring the association between PPROM history in the first pregnancy and maternal and perinatal complications in the next pregnancy. The AMND offered a unique opportunity to study the effects of PPROM using routinely collected population-based data. The data analysed were taken from a geographically stable population and collected at the time of delivery from case notes, thereby minimising selection and recall bias. Changes in clinical practice are unlikely to influence the findings as both cohorts were matched for year of delivery. The consistency and reliability of AMND data are subject to regular checks against the Scottish Morbidity Returns data. Documentation of data, such as time and rupture of labour, are also subjected to numerous consistency checks incorporated within the database, and accuracy of data entry is checked using case note reviews, with greater than 90% variable accuracy confirmed by audits. Our study also accounted for a large number of covariates, thereby increasing the strength of analysis.
As the study is based on secondary data, the presence of missing values and retrospective nature of data collection may have biased the results to some extent. The lack of finer indicators for socioeconomic status and environmental risk factors may have led to residual confounding in our analysis. Women with unrecognised PPROM or PPROM not resulting in a hospital visit would be missed, but these would be few. Additionally, as the study was restricted to primarily Caucasian and primiparous women, the results may not be generalisable to women of non-Caucasian descent, multiparous women or women with restricted healthcare access. Furthermore, as data collection stopped before progesterone prophylaxis for prevention of recurrent preterm birth became a widespread practice, we are unable to comment on the potential impact of this practice on our findings.
Interpretation
The prevalence of PPROM in this study population was 5.2%, which is slightly higher than reported. [2] [3] [4] As AMND collects data from a sole regional tertiary maternity hospital, complicated pregnancies might be over-represented. We confirmed many of the known demographic factors associated with PPROM, including lower socio-economic class, younger maternal age and smoking. Although statistically significant, these demographic factors are not specific to PPROM and are associated with a number of poor obstetric outcomes. Our study findings also confirmed that PPROM in the first pregnancy is linked with maternal and neonatal morbidity outcomes of threatened MC, PET, APH, preterm delivery and LBW in the same pregnancy. [19] [20] [21] [22] The lower risk of PIH reported likely reflects its typical development in later gestation, whereby the increased rates of preterm delivery associated with PPROM may have protected its development.
Our findings on effects of PPROM history on risk of recurrent PPROM and preterm delivery in the second pregnancy are consistent with previous studies. 15, 16, 20, 23 The rates (14.4%) and odds (approximately sevenfold increase) of recurrent in PPROM in our study population were similar to previous reports from the USA. 15, 16 A study by van der Heyden et al. 24 only reported a 9% recurrence rate of PPROM, but focused only on PPROM under 27 weeks of gestation. Studies in the USA also showed that women with previous PPROM history reported a 2.5-to fourfold increased risk of recurrent preterm delivery, 15 ,23 similar to our 2.5-fold increase. The elevated risk of instrument or caesarean delivery related to PPROM history in our study cohort has been reported before. 25 The increased risk of LBW, neonatal infection and death, and admission to neonatal intensive care unit in the second pregnancy reflect PPROM 26 recurrence and are confirmed with our findings. Our study, however, is the first, to our knowledge, to document the associations of previous PPROM history with increased risk of PIH, PE and APH, with PIH and PE risk still persisting in women without a recurrence of PPROM and PE persisting in both early and late subgroup analyses. Plausible explanations include vascular or placental APH, antepartum haemorrhage; BMI, body mass index; CI, confidence interval; LBW, low birth weight; MC, miscarriage; OR, odds ratio; PE, pre-eclampsia; PIH, pregnancy-induced hypertension; PPROM, preterm prelabour rupture of membranes. Model 1: unadjusted. Model 2: *Adjusted for maternal age, social class, smoking status, marital status, BMI, threatened MC at first pregnancy, PIH at first pregnancy, PE at first pregnancy, APH at first pregnancy, mode of delivery at first pregnancy; **Adjusted for maternal age, social class, smoking status, marital status, BMI, threatened MC at first pregnancy, PIH at first pregnancy, PE at first pregnancy, APH at first pregnancy, mode of delivery at first pregnancy, gestational age at delivery at first pregnancy; ***Adjusted for maternal age, social class, smoking status, marital status, BMI, threatened MC at first pregnancy, PIH at first pregnancy, PE at first pregnancy, APH at first pregnancy, mode of delivery at first pregnancy, LBW at first pregnancy.
abnormalities, including increased fragility of vessels or vascular malformations. 27 A recent study by Capece et al. 28 identified STAT1 as a PPROM-specific regulator that has also been shown to be associated with the renin-angiotensin system and therefore blood pressure. 29 They also reported that the main gene networks associated specifically with PPROM were implicated in pathways related to inflammatory processes, vasculogenesis and haematological/coagulation disorders. The events of PPROM, PE, PIH and APH may be a continuum to the development of ischaemic heart disease, stroke and overall cardiometabolic disease, which are associated with a history of spontaneous preterm delivery. 30, 31 The findings of an equal likelihood to second pregnancy suggest either that current policies employing timely and aggressive use of antibiotics and early delivery if signs of chorioamnionitis are protective of tubal factor subfertility or that other processes such as inflammatory may be more important. The findings of increased risk of further PPROM/ preterm delivery are not new, but confirm ongoing risk processes and the need to manage these women as 'high risk' in the next pregnancy as the majority of second pregnancy morbidity related to recurrence of PPROM. Our results suggest that these women are more likely to continue with the next pregnancy, possibly reflecting a change in how they view pregnancy at early gestations. These findings will be helpful for counselling women with a history of PPROM regarding fertility, risk of PPROM recurrence and potential maternal and neonatal outcomes in the next singleton pregnancy. As a significant degree of heterogeneity exists with regards to the clinical management of preterm birth in the UK, 32 where the majority have a history of PPROM, our findings could aid development of a standardised protocol for the management of these high-risk women.
Conclusion
Epidemiological data have been identified as one of the four key elements of the solution pathway for preterm birth research. 33 Most interventions aimed at reducing preterm birth have not shown consistent benefit. 34 Our findings of continued risk of recurrence support inflammatory processes with ongoing associated significant morbidity in the next pregnancy. Attempts have also been made to identify potential determinants of spontaneous preterm delivery and PPROM, 28, 35 highlighting differing responses in regulating inflammation and oxidative stress, 36 and a potential mechanistic pathway involving overproduction of prostaglandin E2 and the protein connexion-43 in response to overextension of the amniotic membrane. 37 Others have identified new candidate genes that may be related to the aetiology of PPROM 28 and explored the role of nuclear progesterone receptors. 38 Some clinics have already started whole-gene sequencing of their patients in the context of research. 39 Following the global trend towards personalised medicine, future research directions should investigate PPROM as an inflammatory-driven disease process, aiming to identify individuals with a genetic predisposition who can then aid the development of sensitive prediction tests and response to novel preventive and treatment interventions.
In conclusion, PPROM in the first pregnancy is associated with significant adverse maternal and perinatal outcomes in the next pregnancy, but not a reduction in likelihood of second pregnancy.
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Additional Supporting Information may be found in the online version of this article: Table S1 Association between previous PPROM with maternal and neonatal outcomes in women with nonrecurring PPROM in the second pregnancy. It is now well established that women whose pregnancies are complicated by pre-eclampsia or spontaneous preterm birth are at increased risk of recurrence in subsequent pregnancies. These risks are higher in the first subsequent pregnancy, and decrease with intervening uncomplicated gestations.
The study of Aris et al. (BJOG 2017; DOI: 10.1111/1471-0528.14462) confirms a number of other studies that have shown that preterm premature rupture of membranes (PPRM) is also more likely to recur in the next pregnancy. The investigators used the Aberdeen Maternity Neonatal Databank, one of the most carefully collected perinatal databases in the world. They studied two decades of primigravid pregnancies and allowed another decade to ensure the optimal follow-up of cases and controls. The resultant high-quality data demonstrate not only that PPRM is more likely to recur in a subsequent pregnancy, but that a history of PPRM in the immediately preceding pregnancy also identifies a group of women at increased risk of other perinatal complications (pre-eclampsia, antepartum haemorrhage, operative delivery, low birthweight, and neonatal unit admission) in association with recurrent PPRM. Women with PPRM in their first pregnancy are at an increased risk for pregnancy-induced hypertension (PIH), pre-eclampsia, operative delivery, and neonatal unit admission, even if PPRM does not recur in the second pregnancy. All of these complications are more likely as the gestational age of the index PPRM case decreases. The findings of increased risk with decreasing gestational age of the index PPRM pregnancy, as well as an increased recurrence risk of both the index complication (PPRM) and others (particularly PIH and preeclampsia), fits well with what is known about the epidemiology of preeclampsia and spontaneous preterm birth. These findings lend further confirmation to the suggestion that all of these complications represent sequelae of inadequate trophoblast invasion and/or dysregulated inflammation.
The report does leave a couple of important questions unanswered. The majority of the index and subsequent pregnancies occurred prior to the widespread use of progesterone for the prevention of recurrent preterm birth.
As the anti-inflammatory properties of progesterone become more widely appreciated, it is possible that progesterone treatment might alter the recurrence risk of these likely interrelated complications.
Another important unanswered question relates to the complication rates in third pregnancies. Previous studies of pre-eclampsia and preterm birth have shown that the outcomes of the penultimate pregnancy are most predictive of the current pregnancy, and that recurrence risks decrease with the number of intervening uncomplicated pregnancies. Although the investigators probably had a substantial number of third pregnancies in their data set, this hypothesis remains unanswered for now.
These issues not withstanding, this report is a valuable contribution to the literature and should serve to remind us of the valuable information to be obtained from a thorough obstetric history.
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